Summary of opinion: Evkeeza, 14/11/2024 Positive
Summary of opinion: Evkeeza, 14/11/2024 Positive
Summary of opinion: Evkeeza, 14/11/2024 Positive
Updated advice to minimise risks of interaction between weight loss medicine Mysimba and opioids
Summary of opinion: Tagrisso, 14/11/2024 Positive
Summary of opinion: Rybrevant, 14/11/2024 Positive
Clinical Data Publication (Policy 0070) webinar - Step 2, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 November 2024, 15:00 (CET) to 14 November 2024, 16:00 (CET)
EMA encourages companies to submit type I variations for 2024 by end November 2024
Human medicines European public assessment report (EPAR): Kizfizo, temozolomide, Status: Opinion
Human medicines European public assessment report (EPAR): Efmody, hydrocortisone, Date of authorisation: 27/05/2021, Revision: 5, Status: Authorised
Expert reports on big data related topics
Social Media Data for Real World Evidence in Regulatory Decision Making